EUVIMEDEUVIMED entdecken
Crossref

How academic medicine can confront commercial determinants of health

Jennifer Lacy-Nichols, Susan Goldstein, Eric Crosbie

BMJ · 10.11.2026 · 395 · e101243

DOI: 10.1136/bmj-2026-101243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMJ, online erschienen am 10.11.2026. Verfasst von Jennifer Lacy-Nichols und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health and Society, Melbourne School of Public Health, University of Melbourne, Melbourne, Australia jlacy@unimelb.edu.au. Die Arbeit nennt 48 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Academic medicine has a crucial role in exposing and minimising the harms created by businesses that prioritise profit over health, though teaching and training, research, and advocacy, argue Jennifer Lacy-Nichols and colleagues

Autor:innen und Institutionen

  • Department of Health and Society, Melbourne School of Public Health, University of Melbourne, Melbourne, Australia jlacy@unimelb.edu.au.
  • South African Medical Research Council/Wits Centre for Health Economics and Decision Science (PRICELESS SA), School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
  • School of Public Health, University of Nevada, Reno, USA.

Zitieren

APA

Lacy-Nichols, J., Goldstein, S., & Crosbie, E. (2026). How academic medicine can confront commercial determinants of health. BMJ, 395, e101243. https://doi.org/10.1136/bmj-2026-101243

Vancouver

Lacy-Nichols J, Goldstein S, Crosbie E. How academic medicine can confront commercial determinants of health. BMJ. 2026;395:e101243. doi:10.1136/bmj-2026-101243

BibTeX
@article{LacyNichols2026,
  author = {Lacy-Nichols, Jennifer and Goldstein, Susan and Crosbie, Eric},
  title = {How academic medicine can confront commercial determinants of health},
  journal = {BMJ},
  year = {2026},
  volume = {395},
  pages = {e101243},
  doi = {10.1136/bmj-2026-101243}
}
Kostenlos starten →